hotspot -WSS

hotspot

author：entertainment 2025-09-29 10:40:40 - browse：466

Sterile capsules for injection line up in a dispensing line — politics coverage from STAT — Adobe

WASHINGTON — The Senate Finance Committee has drafted a bipartisan bill to mitigate drug shortages by rewarding hospitals for business practices that ensure an adequate supply of drugs.

Drug shortages have been a persistent problem for years, and they’re worse than ever, according to a recent report by the American Society of Health-System Pharmacists. Shortages are primarily a problem for hospitals and doctors who regularly administer drugs, including oncologists who have been running out of common chemo drugs. Generic injectables account for 67% of shortages, and more than half of drugs in short supply cost less than $1 per unit, according to the Finance Committee.

Hospitals band together to negotiate drug prices by hiring group purchasing organizations. The biggest three GPOs are estimated to control about 90% of the market for drugs that hospitals buy. Finance Chair Ron Wyden (D-Ore.) said those GPOs can drive prices down so low that manufacturers stop making certain drugs or can’t afford to maintain their facilities, which then leads to manufacturing interruptions. Drugmakers also say GPOs can also be fickle, switching from one manufacturer to another over small savings, leaving drugmakers without the certainty they need to commit to making large volumes of product.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily intelligence on Capitol Hill and the life sciences industry — by subscribing to STAT+.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： New air purifier tech could be key to improving indoor air quality
Next article： As biotech industry slumps, bioscience job market is upside down

WSS

How digital therapeutics firms are pivoting after Pear's bankruptcy

What to make of Gilead’s Trodelvy troubles and Elevation Oncology’s rise

Independent physicians launch a new lobbying group

UnitedHealth has 90,000 doctors — 10% of all physicians in U.S.

Gilead’s Trodelvy fails in lung cancer, raises questions on ADCs

AI generated plenty of interest at JPM but not a lot of trust

leisure time

hotspot

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily intelligence on Capitol Hill and the life sciences industry — by subscribing to STAT+.

explore

Psychedelics group wrestles with new pharma identity

Think you might have Covid

Wildfire smoke exposes gaps in outdoor worker protections

Rep. Raul Ruiz on the physician shortage and more

How to save PrEP access — and even expand it

Readout Newsletter: The latest in Pfizer, Moderna, and Sanofi

BioMarin wins approval for gene therapy to treat hemophilia A

Dewpoint Therapeutics lays off staff after losing partnerships

Over 800 arrested across France in 3rd night of riots after fatal police shooting of teen

Francis Collins on trust in science and how Covid communications failed

hotspot

Dewpoint Therapeutics lays off staff after losing partnerships

What to do when lifesaving products contribute to climate change

As biotech industry slumps, bioscience job market is upside down

Readout Newsletter: The latest in Pfizer, Moderna, and Sanofi

With clinical trial data readouts, here's how to spot spin

Flagship Pioneering launches a new biotech in two countries

hotspot

Wikipedia

leisure time

entertainment